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Background: Peritoneal adhesions are a clinical problem. A key to the understanding of peritoneal ad-
hesions is to study the healing of mesothelial cells within the peritoneal cavity following surgery.
Transforming growth factor beta (TGF-bs) affects this healing process. The aim of this study was to
investigate the effects of different concentrations of TGF-b1 on the healing rate and healing properties of
mesothelial cells.
Materials and methods: Human mesothelial cells from peritoneal ﬂuid were collected, cultured and a
mechanical wound was created. The restoration of the mesothelial surface with and without increasing
concentrations of TGF-b1 was monitored.
Results: The denuded area was restored within 24 h. The healing rate was most extensive between the
ﬁrst and second hour after the damage (61.9  22.8 mm/h). No signiﬁcant difference in healing rate were
observed when increasing levels of TGF-b1 were used. However, higher concentrations of TGF-b1
increased cell size and the cells presented more ﬁbroblast speciﬁc properties. Lower TGF-b1 concen-
trations increased the number of proliferating cells.
Conclusions: This study indicates the importance of high levels TGF-b1 in mesothelial cell healing, mainly
by changing the actual healing properties of the cells. Elevated levels of TGF-b1 might promote meso-
thelial cell transition towards a more ﬁbroblast-like appearance.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Post-surgical adhesions are an important clinical problem.
Trauma to the abdominal cavity, for example caused by abdominal
surgery, is responsible for up to 90% of all adhesions.1 The healing
process of the peritoneal surface is a key component in adhesion
formation.2 The peritoneal surface is a basal membrane of con-
nective tissue with a monolayer of mesothelial cells. These cells
have the ability to regulate, produce and secrete several enzymes in
the peritoneal environment, together with an exclusive ability to
heal damage on the peritoneal surface. A restored peritoneal sur-
face after surgical trauma is a prerequisite to restore the normal
peritoneal environment3 and interactions with surrounding cells.4
Peritoneal surface repair differs from traditional wound healing.
The size of the peritoneal defect is of lesser importance. Small andþ46 31 25 14 63, þ46 31 343
angenete.com (E. Angenete).
ciates Ltd. Published by Elsevier Ltlarge peritoneal defects heal rapidly with similar healing rates
using a simultaneous regeneration of the mesothelial surface
without scar formation. The exact mechanism behind the restora-
tion of the peritoneal surface is yet to be fully uncovered and to
further explore peritoneal healing experimental models using both
cultured omentally derived mesothelial cells5 as well as murine
animal models6 have been used.
The role of transforming growth factor beta (TGF-b) in perito-
neal restoration and repair of the peritoneal surface is assumed to
be of importance although not fully elucidated. HumanTGF-b exists
in three isoforms (TGF-b1-3), all requiring activation to become
biologically active.7 They are major stimulators of matrix protein
deposition known to induce ﬁbrosis8 and there is some evidence
for their role in peritoneal repair through anti-ﬁbrinolytic effects.9
The presence of TGF-b1 in peritoneal tissue10 and ﬂuid11 during
surgery has been described. TGF-b1 has an anti-proliferative effect
on mesothelial cells,8,12,13 however, it has been shown that low
concentrations of TGF-b1 increase the proliferation rate in human
cultured peritoneal mesothelial cells,11 thus suggesting simply
eliminating TGF-b1 is not the way to reduce adhesion formation.d. All rights reserved.
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reduced bleeding in the surgical ﬁeld has been recommended as a
way to minimize adhesion formation.14 Other modiﬁcations of
surgical technique can also affect the levels of TGF-b1, for example
heated inﬂated carbon dioxide results in lower levels of active
TGF-b1,15 prolonged laparoscopic surgery may increase levels
of TGF-b116 and the type of dissection device also affects levels of
TGF-b1, where the use of an ultrasonic device decreases the levels
of TGF-b1 compared to the use of electrocautery.17 In order to
recommend certain surgical adjustments to reduce adhesion for-
mation the role of TGF-b1 in peritoneal surface repair requires
further study as data indicate that both the levels and the timing of
the doses of TGF-b1 are of importance.9,14,18e20 The primary aim of
this study was to evaluate the effect of increasing concentrations of
TGF-b1 on the healing rate and healing properties of mesothelial
cells.
2. Materials and methods
2.1. Ethical considerations
All patients gave written consent and the local ethics committee at the Uni-
versity of Gothenburg approved this study.
2.2. Mesothelial cell culture
Primary isolated human mesothelial cells collected from peritoneal ﬂuid from
patients undergoing surgery at Sahlgrenska University Hospital/Östra were cultured
until the second passage as previously described.21e23 Isolated peritoneal meso-
thelial cells resulted in established cultures that grew to conﬂuence without any
overlapping cells within one week. The recovered and reused media resulted in
islands of mesothelial cells in 80% of the experiments after 24 h. Established cultures
were seen within a few days (Fig. 1).
If not otherwise stated, all cell culture chemicals were purchased from Sigmae
Aldrich (St Louis, Mo, USA). During routine culture, medium E199 supplemented
with 30 IU/mL penicillin and streptomycin (PEST), 1.1 mM L-glutamin, 20% foetal calf
serum (FCS), 0.5 mg/mL hydrocortisone, 50 mg/mL ECGF (prepared according to
Maciag et al.)25 and 10 IU/mL Heparin (Lövens, Sweden) was used.
The mesothelial origin was characterised by morphologic appearance and im-
munostaining.21 Cells were sub-cultured on 12-well cell culture plates (Nunc, Ros-
kilde, Denmark) with a cell density of 1105 cells/well andmaintained for 5e7 days
until 80% conﬂuent. Parallel cultures were stored in cryo tubes in liquid nitrogen for
use in conﬁrmatory tests. Prior to experimental start a pre-incubation for 24 h with
medium containing 1% FCS only was initiated for all cells included in the experi-
mental models of mesothelial injury.
As concentrated FCS could contain TGF-b1 and to conﬁrm that the medium was
contamination-free a commercially available ELISA (Promega Corporation, Madison,
WI, USA) [Falk, 2008#2947]was used todetect TGF-b1. Neither culturemedium (with
20% FCS) nor dilution medium (with 1% FCS) showed detectable levels of TGF-b1.Fig. 1. Established mesothelial culture from free-ﬂoating mesothelial cells. Used cul-
ture media was recovered into new cell culture plates and resulted in established sub-
conﬂuent mesothelial surfaces within a period of 96 h.2.3. Experimental model of mesothelial injury
This model is a traditional mesothelial wound healing assay and a similar wound
healing model using cultured ﬁbroblasts have previously been described.24 In brief
cultured mesothelial cells were grown until conﬂuence at experimental start. By
scraping the monolayer of cells with a sterile plastic pipette (10 mL, D10ST, Gilson,
Middleton, WI, USA) a mechanical injury was created (Fig. 2a). We used a plastic
pipette to create the mechanical damage as we found that the previously described
method using a glass-rod5 easily damaged the plastic surface of the culture plate.
The damage resulting from the pipette was measured with a calibrated size marker
(Fig. 2b) using the Zeiss software (Axiovision, Carl Zeiss AG, Germany). The healing
rate was calculated by dividing the restored distance with the time between each
measurement.
2.4. Mesothelial injury and effects of TGF-b1
After the mesothelial surface was injured, cells were incubated with medium
containing increasing concentrations (from 1  104 to 1  104 pg/mL) of activated
(acidiﬁed) TGF-b1 (R&D, Abingdon, UK) in culture medium with 1% FCS. An equal
number of plates with cells cultured with medium and 1% FCS served as controls.
The mesothelial surfaces were monitored after 1, 2, 4, 6, 8, 24, 48, 72 and 96 h in
order to follow the re-mesothelialisation. The cell sizes along the edge of the me-
chanical damage were calculated and documented using both the individual di-
mensions (heightwidth) of the cell and the tool in the axiocision software plotting
a region of interest around the selected cell. For each concentration of TGF-b1, ex-
periments were run in separate duplicates. Data is represented by four replicates in
each experimental setup.
2.5. Morphology and immunostaining following TGF-b1 treatment
Cultured mesothelial cells were stained with a palette of antibodies to verify the
mesothelial origin as previously described21 and to ascertain that there was no
contamination with other cells. In brief, cultured cells were ﬁxed in 95% ethanol for
5 min. Following a PBS wash for 5 min, cells were pre-incubated for 5 min with 5%
dried fat-free milk (Semper AB, Stockholm, Sweden) in PBS. Each incubation step
was preceded using a PBS wash three times.
The following antibodies were used; mouse anti-human Cytokeratin 4.62
(SigmaeAldrich) diluted 1:20, mouse anti-human Cytokeratin 19 (Dako A/S,
Glostrup, Denmark) diluted 1:40, rabbit anti-human Fibroblast (Dako A/S, Glostrup,
Denmark) diluted 1:50, rabbit anti-human von Willebrand factor (Daco A/S,Fig. 2. A small sterile pipette tip, damaging the cultured mesothelial surface, created
the experimental model of the mesothelial injury (a). The healing rate was then
monitored and calculated by monitoring the remesothelialisation (b).
Fig. 3. Cultured human mesothelial cells with typical monolayer growth pattern,
together with positive immunostaining for human cytokeratin.
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ondary antibodies used were FITC (Fluoroscens isothiocyanate) conjugated against
mouse or rabbit (Dako) depending on primary antibodies used. Control serum from
mouse and rabbit, with the same protein concentration as the primary antibody,
were used as negative controls (Dako). All dilutions were made in PBS-buffer con-
taining 0.5% bovine serum albumin (Sigmaealdrich).
The FITC labelling was detected using UV light connected to the inverted
microscope.
Morphological appearance together with cytokeratin positive cells and absence
of staining for ﬁbroblast and endothelial speciﬁc properties indicates mesothelial
origin (Fig. 3).
2.6. Statistics
The KruskaleWallis test was used to detect overall differences in healing rates
and if signiﬁcant, a Bonferroni corrected ManneWhitney U test was performed
between individual groups. A non-corrected p-value <0.05 were consideredFig. 4. Healing rate and mesothelial recovery after mechanical damage on the mesothelial su
after the mechanical damage, followed by an increase within 1e2 h and then a decrease
restoration during time is described using bar graphs (b: Right Y-axis, Mean  SD).statistically signiﬁcant and when all groups were compared a corrected signiﬁ-
cance level of <0.01 was used. When healing rate and mesothelial restoration were
correlated with time the Spearman Rank Correlation was used. Results are pre-
sented as mean  standard deviation (SD) in the ﬁgures. All statistical calculations
were performed using the StatView 5.0 package (Abacus Concepts, Berkeley,
CA, USA).
3. Results
3.1. Experimental healing rate after mesothelial injury
Mechanical damage resulted in a denuded injury with an
average distance of 409.7  38.7 mm (Fig. 2b). The injury was
completely restored after 24 h (Fig. 4a). Healing ratewasmost rapid
between the ﬁrst and second hour after damage; 61.9  22.8 mm/h
(Fig. 4b). Both healing rate and mesothelial injury restoration were
correlated with time, for healing rate (r2 ¼ 0.351, p ¼ 0.025) and
mesothelial injury restoration (r2 ¼ 0.978, p < 0.0001). Mesothelial
injury restoration reached 90% conﬂuence within 8e10 h (Fig. 4c).
3.2. TGF-b1 effects on mesothelial healing rate and healing
properties
No difference in healing rate was seen between the different
TGF-b1 concentrations compared to control medium. However, af-
ter 24 h mesothelial cells treated with higher concentrations of
TGF-b1 healed the injured area by increasing in cell size with
12800  6700 mm2 (p < 0.001, n ¼ 15) while cells with lower con-
centrations of TGF-b1 seemed to heal with an increase in number
with 2900  2400 mm2 (p ¼ 0.217, n ¼ 15), compared to
3800  2500 mm2 for untreated medium control. This was also re-
ﬂected in cell counts where cells treated with lower concentrations
of TGF-b1 healed by an increase in number, with 56000  17100
cells/cm2 compared to 11000  6800 cells/cm2 for high concen-
trations of TGF-b1 compared to 36000  18500 cells/cm2 for the
untreated control. Additionally, 72 and 96 h after mechanical injury
mesothelial cells treated with higher concentrations of TGF-b1
developed a more elongated cell type similar to ﬁbroblasts with a
higher number of multi-nuclear cells. This effect could be seen after
72 h and sustained after 96 h of treatment withmore ﬁbroblast-like
appearance and multi-layer growth pattern in a dose-dependent
manner (Fig. 5).rface after 24 h. The line graph (Mean  SD) indicates lower healing rates immediately
until the mesothelial damage was recovered (a: Left Y-axis). The mesothelial injury
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ﬁbroblast speciﬁc antibodies as well as antibodies for mesothelial
origin. Speciﬁc growth patterns with ﬁbroblast like cells, growing in
several layers, were also present in contrast to cells with low or no
TGF-b1 (Figs. 5 and 6).
4. Discussion
This study increases the knowledge regarding peritoneal heal-
ing, which in the future may allow surgical techniques to
adjust accordingly to reduce adhesion formation. The aim was to
explore the role of different concentrations of TGF-b1 on peritoneal
healing as it has previously been reported that the proliferation rate
of mesothelial cells decreases with higher concentrations ofFig. 5. Micrographs of the mesothelial surface when time and concentrations of TGF-b1 were
(right column) concentrations of TGF-b1. Increasing time and concentration seemed to hav
ﬁbroblast like appearance, with a multi-layer growth pattern.TGF-b112,25 and that the proliferation rate increases with low con-
centrations similar to levels found in the human abdominal cavity
during surgery.11 Unexpectedly we found no relationship between
proliferation rate and healing rate, but our results indicate that
healing rate may not be the most important measure; perhaps the
size and number of cells are more important. Cells with higher
concentrations of TGF-b1 healed the injured area by increasing in
size, while cells treated with lower concentrations of TGF-b1
seemed to heal by an increase in number. The latter result may
partly explain our previous ﬁndings.11
Our data also suggest that higher levels of TGF-b1 for a long time
affect the healing properties of the peritoneum other than by
decreasing healing rate, as the mesothelial cells changed their
morphology into a ﬁbroblast like appearance. Mesothelial cells maycompared. Mesothelial cells with control medium (left column) compared with higher
e effect on the mesothelial morphology in the cultures, turning the cells into a more
Fig. 6. Immunostaining of mesothelial cells using ﬂuorescence isothiocyanate (FITC) and a palette of anti-human antibodies. Micrographs indicating a mesothelial origin in cells
treated with no TGF-b1 by positive staining for cytokeratin and negative for ﬁbroblast (Fig. 6aee). Interestingly, with higher concentrations of TGF-b1 the positive staining for
cytokeratin sustained together with a positive staining for ﬁbroblast speciﬁc antigen (6fej).
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indicate that increased levels of TGF-b1 stimulates this transition. It
is known that TGF-b promotes epithelial e mesenchymal e transi-
tion (EMT),26 and our ﬁndings are most probably reﬂect this action
by TGF-b1. The transition to ﬁbroblast like appearance again in-
dicates that TGF-b1 has the capacity to affect the healing process by
ﬁbrosis, which also increases adhesion formation.
The healing ratewas highest within the ﬁrst hour, which likely is
due to a gradual decreased degree of healing as the cells cover the
damaged surface. However, after 24 h the damaged area was
restored which is in contrast to the study performed by Yung et al.5
where the injury was healed after 72 h. In the current study we
used primary isolated mesothelial cells from peritoneal ﬂuid. It
might be that mesothelial cells derived from peritoneal ﬂuid and
from the omentum react differently to mechanical injury, which
could explain the difference in healing rate between our present
study and the study performed by Yung.5
Similar to what has been described by Mutsaers et al.27 free-
ﬂoating cells that in routine cell culture, in vitro, are discarded
together with the used culture media could form new established
cultures of cells. In 4 out of 5 independent experiments cells were
present and had the ability to form new cultures that increased in
number and formed established cultures within a short period of
time. This might be an important mechanism in the peritoneal
environment for the restoration of mesothelial surfaces after
damage.
Taken together, this study suggests a role for TGF-b1 in meso-
thelial cell recovery as it affects the mesothelial cell recovery
through morphology changes rather than only proliferation rate.
Future studies should continue to focus on the effects of high levels
of TGF-b1 on mesothelial cell regeneration as reduction of TGF-b1
levels may decrease clinically signiﬁcant adhesions.
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